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Abstract The purpose of this study was to compare the
outcome, complications and survival of the three most
commonly used surgical reconstructions of the proximal
humerus after transarticular tumour resection. Between 1985
and 2005, 38 consecutive proximal humeral reconstructions
using allograft-prosthesis composite (n=10), osteoarticular
allograft (n=13) or a modular tumour prosthesis (n=14)
were performed in our clinic. The mean follow-up was
ten years (1–25). Of these, 27 were disease free at latest
follow-up (mean 16.8 years) and ten had died of disease. The
endoprosthetic group presented the smallest complication
rate of 21% (n=1), compared to 40% (n=4) in the allograft-
prosthesis composite and 62% (n=8) in the osteoarticular
allograft group. Only one revision was performed in the
endoprosthetic group, in a case of shoulder instability.
Infection after revision (n=3), pseudoarthrosis (n=2), frac-
ture of the allograft (n=3) and shoulder instability (n=4)
were the major complications of allograft use in general.
Kaplan-Meier analysis showed a significantly better implant
survival for the endoprosthetic group (log-rank p=0.002).At
final follow-up the Musculoskeletal Tumour Society scores
were an average of 72% for the allograft-prosthetic compos-
ite (n=7, median follow-up 17 years), 76% for the osteo-
articular allograft (n=3, 19 years) and 77% for the
endoprosthetic reconstruction (n=10, 5 years) groups. An
endoprosthetic reconstruction after transarticular proximal
humeral resection resulted in the lowest complication rate,
highest implant survival and comparable functional results
when compared to allograft-prosthesis composite and osteo-
articular allograft use. We believe that the surgical approach
that best preserves the abductor mechanism and provides
sufficient surgical exposure for tumour resection contributed
to better functional results and glenohumeral stability in the
endoprosthetic group.
Introduction
Limb salvage following tumour resection about the proximal
humerus in the adult patient poses significant surgical
challengesasitisoftenlimitedbysurgical lossofsurrounding
functional soft tissue stabilisers of the glenohumeral joint.
Although studies have emphasised the possibility of deltoid
muscle and axillary nerve sparing without compromising
oncologicalsurgicalmargins,transarticulartumourresections,
including part of the deltoid muscle and rotator cuff, are
frequently reported [1–4]. In the adult patient functional
reconstruction after transarticular proximal humeral resection
is most frequently performed using either osteoarticular
allograft (OA), endoprosthesis (EP) or a combination of
both [4–6]. As a broad range of functional results and
complication rates are reported for all three, the choice for
one or the other remains one of surgical experience, time set
and local preference [2, 4, 6–8]. Mid- and long-term
complications, such as fracture, subchondral collapse and
infection, are however reported less frequently in prosthetic
reconstructions. Conversely, glenohumeral instability is
considered to be less frequent in patients with a somewhat
more biological repair. However, in both OA and allograft-
prosthesis composite (APC) reconstruction, instability
caused by rotator cuff dysfunction is reported to be between
5% and 19% of cases compared to between 11% and 31%
after endoprosthetic reconstruction (EPR) [4, 7, 9]. Again, an
intact abductor mechanism was associated with increased
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different surgical options both concluded that APC is
favoured above EPR in young patients, as functional results
are somewhat better, but in the older patient EP is preferred
for its superior implant survival [4, 6, 7].
This retrospective cohort series compares three surgical
options (EP, OA and APC) for implant- and resection-
related outcome parameters to determine which type of
reconstruction, after primary transarticular resection, could
in the long term lead to optimal functional results, patient
and implant survival. Additionally, we hypothesised that
optimal functional results can be achieved when the deltoid
muscle, including the axillary nerve, is left unharmed using
a new deltoid-preserving surgical approach.
Patients and methods
Between 1985 and 2007, 37 consecutive proximal humeral
reconstructions using either APC (n=10), OA(n=13) or a
modular tumour prosthesis (n=14) were performed in our
clinic. A total of 33 patients underwent limb salvage
resection for a primary bone tumour (9 benign and 24
malignant) and four for metastatic disease. The histological
diagnosis was osteosarcoma in ten, Ewing’s sarcoma in
two, high-grade chondrosarcoma in 11, giant cell tumour in
eight, and malignant fibrous histiocytoma (MFH) and
aneurysmatic bone cyst in one. Patients with metastatic
disease were treated with EP in three cases and APC in one.
Primary bone lesions as described above were evenly
divided between all three groups.
All patients were treated with the appropriate (neo)
adjuvant chemo- and/or radiation therapy using the appro-
priate treatment protocols. Chondrosarcomas and benign
bone lesions were treated by surgical resection only.
There were 21 male and 16 female patients. Their mean
age was 44.8 years (range 16–83).
The mean follow-up was ten years, ranging from
nine months to 25 years. None of the surviving patients
(n=28) were lost to follow-up (mean follow-up 16.9 years,
ranging from 32 months to 25 years).
We retrospectively analysed all medical records for
patient characteristics, age at diagnosis, diagnosis, surgical
treatment and approach, duration of follow-up, integrity of
abductor mechanism, humeral resection length measured
from the tip of the greater tuberosity, cortical destruction,
resection margins, adjuvant treatment, postoperative compli-
cations, oncological parameters including overall survival,
and local or systemic relapse. Event-free and implant
survival are described using a Kaplan-Meier analysis.
Functional assessment at the time of final follow-up was
assessed using the Musculoskeletal Tumour Society (MSTS)
functional scores for patients still in follow-up (the MSTS
score range between 0 and 30 is presented here as a
percentage: raw score/30) [10]. The shoulder abductor
mechanism was considered compromised when the rotator
cuff or axillary nerve was sacrificed and/or greater than 50%
of the deltoid muscle was resected [7].
Patients treated with allograft (OA and APC) were on
average ten years younger when compared to the EP group
(33, 34 and 44 years, respectively, p=0.005). Further
patient characteristics are summarised in Table 1. Nine
patients died of disease (DOD) at a mean of 4.5 years
postoperatively (range 2–6 years), and one patient died of
hepatocellular carcinoma five years postoperatively.
Surgical technique
All patients were surgically treated by a single experienced
musculoskeletal oncologist (AHMT). The surgical ap-
proach was an extended deltopectoral in 13 or a distal
deltoid flap approach in 24 shoulders. In contrast to the
classic deltopectoral approach, this deltoid flap approach
releases the deltoid muscle as one flap, including the
overlying skin, from its insertion on the humeral diaphysis
to provide for adequate and safe exposure of the complete
proximal humerus, axillary and if necessary radial nerve
and axillary fossa [11–13]. Using this approach we could
spare the deltoid muscle and axillary nerve without
sacrificing intended wide surgical margins in all but three
patients, in which the axillary nerve was involved in the
tumour. All were transarticular resections, leaving the
glenoid intact (Table 2). The humeral diaphysis was
isolated at least 2 cm from the most distal part of the
lesion and cut using an oscillating saw. If possible the
deltoid insertion was, if not already released, spared for
later reinsertion. If appropriate the deltoid insertion was
released, the axillary nerve was spared and the rotator cuff
was cut at its insertion on the native humeral head in order
to provide sufficient tendon length for subsequent recon-
struction. Reconstructions were performed using techniques
described in earlier reports [6, 7].
OAs and APCs were templated and ordered preoperatively
from a well-established tissue bank (National Bone Bank/BIS
Foundation, Leiden, The Netherlands). After aseptic recovery
and processing, all allograftsfor OA and APC reconstructions
were fresh-frozen at −80°C. To assure optimal articular
cartilage integrity none were secondarily sterilised with
chemicals or radiation. All EPRs were performed using the
MUTARSmodularproximalhumeralprosthesis(Implantcast,
Buxtehude, Germany) and APC reconstructions using a bio-
modular shoulder prosthesis (Biomet, Warsaw, IN, USA).
EPRs were only cemented (n=4) when press-fit fixation was
prevented by large diaphysis diameter, using a third-
generation technique. APC reconstructions were cemented
into the allograft and subsequently fixated to host distal
1376 International Orthopaedics (SICOT) (2011) 35:1375–1380humerus using supplemental plate fixation. Compression
plate and screw fixation was used for all OA reconstructions.
In the case of the modular tumour prosthesis, we used a
Trevira tube surrounding the proximal humeral prosthesis
(MUTARS, Implantcast, Buxtehude, Germany) to reattach
the principal soft tissues. In allograft use, the surrounding
soft tissues were reattached to the appropriate insertion on
the allograft.
All were treated with the same postoperative functional
regime. For the first four weeks patients were kept in a sling
and only pendulum movement was allowed, after which
slow progressive exercises were started.
Descriptive statistics were performed for all groups and
are presented in Tables 1 and 2. Implant survival was
assessed using the Kaplan-Meier method; differences in
survival were assessed using the log-rank (Mantel-Cox) test,
assuming censored patients (local recurrence or DOD)
continued to fail at the same rate as those remaining in the
analysis. Preoperative patient characteristics and incidence
of complications were assessed using chi-square analysis or
Fisher’s exact test (e.g. diagnoses, preoperative pathological
fractures, abductor compromise, postoperative infection,
fracture, instability, non-union, proximal migration, total
complications and complications requiring reoperation,
prosthesis revision). Correlations between surgical tech-
nique, radiological and functional results were assessed
using a linear regression analysis. Correlations between
proximal migration and functional results were assessed in a
subgroup analysis leaving out all patients who had revision
surgery, as this was indicated as a significant confounder for
functional outcome. Analysis was performed using SPSS
Version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Postoperative results for all three reconstruction groups are
presented in Table 2.
Table 2 Postoperative results
Infection deep/
superficial
Fracture/
non-union
Subluxation/
dislocation
Chondrolysis Proximal
migration,
n (%)
Surgical
revision,
n (%)
Local
recurrence,
n (%)
DOD/
DOAD,
n (%)
AWOD,
n (%)
MSTS,
n (%)
All 2/1 3/2 4/2 6 20 12 5 10 27 75.5%
OA
(n=13)
1/0 1/2 1/0 6 (100%
a) 6 (46%) 8 (61%) 3 (23%) 6 (46%) 7 (54%) 77%
APC
(n=10)
1/1 2/0 3/1 - 8 (80%) 3 (30%) 0 2 (20%)
b 8 (80%) 72%
Modular tumour
prosthesis
(n=14)
0/0 0 0/1 - 6 (42%) 1 (7%) 2 (14%) 2 (14%) 12 (86%) 77%
n=23 patients alive with surviving index surgery; OA, n=6 [3 patients with no or mild symptoms of chondrolysis (MSTS 74%), 3 patients with
shoulder prostheses inserted (MSTS 79%)]; APC, n=7; EP, n=10
DOD died of disease, DOAD died of another disease, AWOD alive without disease
a100% of surviving patients (6/6)
bOne DOD and one DOAD
Table 1 Surgical and oncological characteristics
Approach Axillary
nerve
intact
Rotator
cuff
intact
Abductor
mechanism
intact
Free
(marginal)
margins
Mean
resection
(min.-max.)
Adjuvant
radiation
therapy
a
Pathological
fracture
Local
recurrence
Deltopectoral Deltoid
flap
All (n=37) 10 (32%) 27 (78%) 31 (84%) 35 (95%) 31 (84%) 31 (84%) 14.2 (7–21) 5 (14%) 6 (20%) 5 (14%)
OA (n=13) 4 (31%) 9 (69%) 10 (77%) 12 (92%) 10 (77%) 11 (85%) 15.4
(10–21)
2 (15%) 2 (15%) 2 (15%)
APC (n=10) 5 (50%) 5 (50%) 9 (90%) 9 (90%) 9 (90%) 8 (80%) 12
(7–20)
0 2 (20%) 0
Modular
tumour
prosthesis
(n=14)
1 (7%) 13 (93%) 12 (86%) 14 (100%) 12 (86%) 12 (86%) 9.6
(6.5–14)
3 (21%) 2 (14%) 3 (21%)
aWas only used for metastatic disease
International Orthopaedics (SICOT) (2011) 35:1375–1380 1377Complications
Non-union, fracture, (sub)luxation and infection were
significantly more frequent in patients treated with allograft
(OA and APC) (p=0.03). Infection only occurred after
revision surgery (n=3); no primary infections were found.
Proximal migration was observed in 20 patients with their
index surgery still intact (74%), but was most commonly
observed in the APC group (n=8, 80%).
In five cases (two osteosarcomas and three chondrosarco-
mas) local recurrence followed after intralesional resection
due to the presence of a pathological fracture or insufficient
or marginal margins around the neurovascular bundle.
Surgical approach
The distal deltoid flap approach resulted in a significantly
larger percentage of free surgical margins (93 vs 60%, p=
0.05) and an observed higher frequency of an intact and
functional abductor mechanism (93 vs 70%, p=0.07), when
compared to the extended deltopectoral approach. Addi-
tionally, it resulted in significantly less proximal migration
of the humeral head (62 vs 100%, p=0.05). No differences
in wide resection margins were observed.
Functional results
Functional scores for patients treated with OA are provided
for all patients left alive in this group (n=6). Three patients
were treated for painful chondrolysis using a cemented
hemiprosthesis. Of the three patients with their index
surgery in situ all presented with chondrolysis. Only one
was asymptomatic; the other two preferred not to have
revision surgery yet. MSTS scores differed only slightly
between these two groups, 74 vs 79%. The presence of
proximal migration resulted in significantly lower MSTS
scores (72 vs 88%, p=0.01). Corrected for revision surgery,
proximal migration was the only significant negative
predictive factor for postoperative MSTS scores (R
2=0.4,
p=0.01).
Survival analysis
Survival analysis using a Kaplan-Meier curve for all three
types of reconstruction is presented in Fig. 1. Five-year
survival with revision surgery as endpoint for the OA group
was significantly lower at 9% (n=1) when compared to
APC (n=6, 60%) and EPC (n=8, 88%) (p=0.001). Implant
survival with implant removal as endpoint resulted in an
implant survival of 100% in the EP group. This was
significantly higher when compared to OA (61%) and APC
(90%) (p=0.002). The observed difference between the
implant survival for patients with a deltopectoral approach
(33%) compared to a distal deltoid flap approach (61%)
was also significant (p=0.03) (Fig. 2).
Discussion
Proximal humeral reconstruction has anecdotally been
reported to have serious postoperative functional deficit
and high complication rates. The use of allograft is
frequently promoted for restoration of bone stock and
anatomical reconstruction of soft tissues. Some studies have
stated that this anatomical repair resulted in better postop-
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contrast, chondrolysis, allograft fracture and non-union
have also been introduced as reasons not to consider OA
for standalone proximal humeral reconstruction [14–16].
The additional use of a cemented prosthesis into the
allograft, preferably bridging the allograft and fixed into
the healthy autologous humeral bone, should prevent
chondrolysis and allograft fracture but are still susceptible
to non-union, osteolysis and loosening [2, 4, 7]. Modular
mega-prostheses for proximal humeral reconstruction pre-
sented a solution for complications inherent to biological
repair, but were presumed prone to (sub)luxation and
offered less healthy bone to work with when revision
surgery was warranted [4]
We postulated that use of an EP alone would diminish
surgical complications and increase implant survival. In
addition, we assumed that the use of a deltoid flap approach
would achieve better abductor mechanism and rotator cuff
preservation leading to improved functional results and
implant survival.
Our series of proximal humeral reconstruction has
underlined the high complication risk for OA use alone.
The use of allograft combined with a primary cemented
shoulder prosthesis did significantly improve implant
survival, but was still subject to a higher number of surgical
complications in need of surgical revision, when compared
to EP use alone. Additionally, it showed that functional
results and MSTS scores for the use of EP were not inferior
to that of APC reconstructions. Mid- and long-term event-
free implant survival was significantly better for EP use
alone. When compared to findings in recently presented
studies, we found comparable functional results and
implant survival statistics for all three groups (Table 3)
[1–7]. However. functional comparison remains very much
dependent on tumour localisation, joint and soft tissue
involvement, use of postoperative radiotherapy and was
reported using several outcome scores. It was therefore not
included in Table 3 [2, 4, 6, 7, 17].
It must be noted that time set and local preference for
one or the other technique should be regarded as major
confounders of postoperative results and implant survival.
Assessment of the two different surgical approaches
(extended deltopectoral and distal deltoid flap) presented an
observational difference in implant survival and significant
difference in abductor mechanism preservation, proximal
migration and surgical resection margins all in favour of the
deltoid flap approach. The distal deltoid flap approach
presented us with a safe and reliable surgical exposure of
the proximal humerus providing for wide resection of bony
and soft tissue tumour components, without compromise of
the deltoid muscle, axillary nerve and rotator cuff muscles.
We believe this may explain the significant difference in the
incidence of proximal migration.
Study limitations
Although our results did support our study hypothesis,
conclusions drawn must be read in light of our study
limitations. The primary limitation must be its retrospective
character and inevitable small numbers. Additionally the
multiform patient characteristics and surgical techniques
account for the limited statistical importance of this paper.
Still the clear and significant differences in implant survival
and complication rates put forward a slightpreferencetowards
prosthetic use alone in proximal humeral reconstruction.
Although no patients were lost to follow-up, only 27 patients
were alive without disease during final follow-up. Of these,
only 23 patients still had their index surgery in place. This
must have introduced a serious confounder due to selection
bias as non-survivors were assumed to have continued to fail
at the same rate as those remaining in the analysis.
Additionally, the superior results for the deltoid flap
approach when compared to the deltopectoral approach
may have been subject to some indication bias as the
deltoid flap approach was probably not used when tumour
boundaries included the deltoid muscle itself. Finally, the
time frame of the study does introduce bias due to surgical
experience, new surgical techniques and materials, but this
is inevitable when reporting on the treatment of this
relatively rare tumour location.
Complications
Although infection is regarded as a major complication of
allograft and prosthetic reconstruction after limb-salvage
s u r g e r y ,t h i sw a so n l yr a r e l ys e e ni no u rs e r i e s .A l lt h r e e
deep infections occurred after revision surgery for other
reasons and this was coherent with recent literature [4, 7].
Table 3 Overview of recent literature for the three types of reconstruction [2, 4, 6, 7, 14, 16]
Reconstruction n Mean follow-up (months) Complication rate (%) Reoperation rate (%) Implant survival (without revision) (%)
Allograft 52 72 49 36 62
Composite 52 76 40 21 88
EPR 149 43 11 7 91
International Orthopaedics (SICOT) (2011) 35:1375–1380 1379In only one of these patients could the index reconstruc-
tion be preserved; the other two were revised with the use
of an EP.
Glenohumeral instability and proximal migration were
assumed to be less frequent in allograft use as musculotendi-
nous reconstruction would be superior when compared to EP
use alone [4, 7]. Our results do not support this conclusion as
instability and proximal migration were equally divided in
both APC and EP groups. The use of an periprosthetic
Trevira tube to securely reattach the deltoid, pectoral and
rotator cuff muscles around the proximal humeral prosthesis
may have improved our results [18].
Authors’ conclusions
The retrospective character and small numbers of all studies
including our own limit the possibility for specific subgroup
analysis to assess the influence of patient characteristics,
surgical technique and implant choice on the reconstruction
and tumour-related complications, functional outcome and
reconstruction survival. Specific factors improving functional
results and decreasing the need for surgical revision are
undoubtedly imminent to provide surgeons and patients alike
with the appropriate choice of proximal humerus reconstruc-
tion.OurresultssupporttheuseofEPRafter tumourresection
of the proximal humerus over APC and OA reconstructions,
because implant survival is superior and complication rates
necessitatingrevisionsurgerymuchlower,withoutnegatively
influencing the postoperative functional results. Additionally,
we would advocate a surgical technique that poses the least
danger of abductor mechanism compromise, offers sufficient
surgical exposure and presents safe possibilities for wide
surgical margins [1]. The use of the distal deltoid flap
approach is therefore advocated.
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